Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S036 - Role of Dermatologist in Management of Skin Disease in Solid Organ Transplant Recipients

Sunday, February 18; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Detect and manage high risk skin cancer in solid organ transplant recipients.
  • Determine a treatment plan with field therapy in solid organ transplant recipients.
  • Discuss the management of skin disease in adult and in pediatric organ transplant

Description

This session highlights the management of skin disease and various skin cancers in adult and pediatric organ transplant recipients and is targeted to the general dermatologist. Medical and surgical options as well as field therapies, chemoprevention and new technologies such as non-invasive imaging will be presented.

Disclosures

  • Carter, Joi B., MD: Millennium Pharmaceuticals – Independent Contractor(Fees); Soligenix, Inc – I(Fees);
  • Colegio, Oscar, MD, PhD: no financial relationships exist with commercial interests.
  • Coughlin, Carrie C, MD: no financial relationships exist with commercial interests.
  • Hanlon, Allison, MD, PhD: Merck & Co., Inc – C(Fees);
  • Krunic, Aleksandar L. J., MD, PhD: no financial relationships exist with commercial interests.
  • Kurtzman, Drew, MD: no financial relationships exist with commercial interests.
  • Nghiem, Paul, MD, PhD: Bristol-Myers Squibb – I(Grants/Research Funding); EMD Serono – C(Fees); Merck & Co., Inc – A(H); Sanofi/Regeneron – A(H);
  • Paragh, Gyorgy, MD, PhD: ADC Therapeutics – C(NC); Buffalo BioLabs, LLC – C(NC); Cleveland Bio Labs – C(Grants/Research Funding); Iovance Biotherapeutics – C(H); Merck & Co., Inc – I(Grants/Research Funding);
  • Samie, Faramarz H., MD: no financial relationships exist with commercial interests.
  • Sharma, Amit, MD: no financial relationships exist with commercial interests.
  • Somani, Ally-Khan, MD, PhD: Aviragen Therapeutics Inc. – C(Fees); Castle Biosciences, Inc – I(Grants/Research Funding); Cook Biotech Inc. – A(Fees);
  • Stasko, Thomas, MD: no financial relationships exist with commercial interests.
  • Tkaczyk, Eric Robert, MD, PhD: no financial relationships exist with commercial interests.
  • Zeitouni, Nathalie C., MD: Genentech, Inc. – SP(H), SP(NC);
Schedule
Sunday, February 18
1:00 PM
Dr. Zeitouni / Welcome and Introduction
1:10 PM
Dr. Stasko / Current Perspectives on Transplant Dermatology
1:22 PM
Dr. Paragh / Melanoma updates
1:34 PM
Dr. Carter / Cutaneous Lymphomas in SOTR
1:46 PM
Dr. Samie / Ocular Tumors
1:58 PM
Dr. Coughlin / Pediatric Organ transplant recipients
2:10 PM
Dr. Nghiem / Merkel cell carcinoma in the immune suppressed setting
2:22 PM
Dr. Somani / Surgical Dermatology Biopsy Burnouts
2:34 PM
Dr. Tkaczyk / Non invasive imaging
2:46 PM
Dr. Hanlon / Topical and intralesional alternatives
2:58 PM
Dr. Zeitouni / Photodynamic Therapy: Where are we now?
3:10 PM
Dr. Sharma / Chemoprevention for the Transplant Recipient
3:22 PM
Dr. Kurtzman / Psoriasis and biologics
3:34 PM
Dr. Krunic / Nail Disease and Nail Surgery
3:46 PM
Dr. Colegio / Benign Conditions
Event Details
  • Date
    Sunday, February 18
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 28D
  • CME Credits
    3.00
  • Type
Directors/Co-Directors
  • Nathalie C. Zeitouni, MD, FAAD
Speakers
  • Aleksandar L. J. Krunic, MD, PhD, FAAD - Handout
  • Allison Hanlon, MD, PhD, FAAD
  • Ally-Khan Somani, MD, PhD, FAAD
  • Amit Sharma, MD, FAAD
  • Carrie C Coughlin, MD, FAAD
  • Drew Kurtzman, MD, FAAD
  • Eric Robert Tkaczyk, MD, PhD, FAAD - Handout
  • Faramarz H. Samie, MD, FAAD
  • Gyorgy Paragh, MD, PhD, FAAD
  • Joi B. Carter, MD, FAAD
  • Oscar Colegio, MD, PhD, FAAD
  • Paul Nghiem, MD, PhD, FAAD
  • Thomas Stasko, MD, FAAD